Taipei, July 23 (CNA) The amount of capital raised by public companies in Taiwan fell substantially in the first half of this year as rising inflation led to rate hikes from the central bank, according to the Financial Supervisory Commission (FSC).
TAIPEI, Taiwan, July 05, 2022 (GLOBE NEWSWIRE) OBI Pharma, a Taiwan biopharma company (TPEx: 4174), today announced discontinuation of the Phase 1/2 Study for OBI 888, a Globo H antibody, upon completion